Compare Novartis AG (NVS) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Procter & Gamble Co — how do they compare? Novartis AG trades at $149.81 (market cap $290.25B), while Procter & Gamble Co trades at $148.25 (market cap $347.26B). The key difference: Procter & Gamble Co is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | PG | |
|---|---|---|
Market Cap | $290.25B | $347.26B |
Sector | Health | Consumer Staples |
52-Week High | $168.62 | $167.18 |
52-Week Low | $113.50 | $138.10 |
Enterprise Value | $330.27B | $372.74B |
Dividend Yield | 3.17% | 2.92% |
Volume | — | 6,423,436 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Procter & Gamble (PG) trades at $148.12, down 1.23% on the day, with a bullish technical outlook supported by moving averages and key resistance at $150. The company shows steady revenue growth, with 2025 revenue at $84.28 billion and net income of $15.97 billion, alongside consistent quarterly earnings beats. Recent news highlights PG's dividend reliability and strategic partnerships, such as the WNBA deal announced on April 7, 2026.
PG offers a stable investment with a strong dividend history and moderate growth, but faces risks from premium valuations and economic sensitivity. Analyst consensus is bullish with a $161.71 price target, though near-term upside may be limited by high P/E and P/S ratios relative to peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
